FRACTYL HEALTH INC(NASDAQ:GUTS) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to GUTS. GUTS was compared to 189 industry peers in the Health Care Equipment & Supplies industry. GUTS may be in some trouble as it scores bad on both profitability and health. GUTS does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year GUTS has reported negative net income.

In the past year GUTS has reported a negative cash flow from operations.

In the past 5 years GUTS always reported negative net income.

In the past 5 years GUTS always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of GUTS (-65.17%) is worse than 72.49% of its industry peers.

Looking at the Return On Equity, with a value of -247.79%, GUTS is doing worse than 78.84% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-65.17%
ROE	-247.79%
ROIC	N/A

ROA(3y)-97.75%

ROA(5y)-92.56%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

GUTS has a worse Gross Margin (46.24%) than 60.85% of its industry peers.

The Profit Margin and Operating Margin are not available for GUTS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	46.24%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

GUTS does not have a ROIC to compare to the WACC, probably because it is not profitable.

GUTS has more shares outstanding than it did 1 year ago.

The number of shares outstanding for GUTS has been increased compared to 5 years ago.

GUTS has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -7.19, we must say that GUTS is in the distress zone and has some risk of bankruptcy.

GUTS has a worse Altman-Z score (-7.19) than 75.66% of its industry peers.

GUTS has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.

GUTS has a worse Debt to Equity ratio (1.06) than 76.19% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.06
Debt/FCF	N/A
Altman-Z	-7.19

ROIC/WACCN/A

WACC9.08%

2.3 Liquidity

A Current Ratio of 3.63 indicates that GUTS has no problem at all paying its short term obligations.

GUTS has a better Current ratio (3.63) than 62.43% of its industry peers.

A Quick Ratio of 3.63 indicates that GUTS has no problem at all paying its short term obligations.

GUTS has a better Quick ratio (3.63) than 68.78% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.63
Quick Ratio	3.63

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

GUTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.85%, which is quite good.

The Revenue for GUTS has decreased by -22.50% in the past year. This is quite bad

EPS 1Y (TTM)17.85%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-7.02%

Revenue 1Y (TTM)-22.5%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-57.14%

3.2 Future

The Earnings Per Share is expected to grow by 8.48% on average over the next years. This is quite good.

Based on estimates for the next years, GUTS will show a very strong growth in Revenue. The Revenue will grow by 536.61% on average per year.

EPS Next Y2.89%

EPS Next 2Y-4.99%

EPS Next 3Y8.48%

EPS Next 5YN/A

Revenue Next Year-100%

Revenue Next 2Y-41.42%

Revenue Next 3Y536.61%

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GUTS. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GUTS. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-4.99%

EPS Next 3Y8.48%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for GUTS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

FRACTYL HEALTH INC

NASDAQ:GUTS (5/2/2025, 8:00:01 PM)

After market: 1.65 +0.07 (+4.43%)

1.58

+0.31 (+24.41%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)03-03 2025-03-03/amc

Earnings (Next)05-19 2025-05-19

Inst Owners85.32%

Inst Owner Change0.02%

Ins Owners4.25%

Ins Owner Change2.82%

Market Cap77.29M

Analysts85

Price Target9.52 (502.53%)

Short Float %6.08%

Short Ratio11.55

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-5.66%

Min EPS beat(2)-17.2%

Max EPS beat(2)5.88%

EPS beat(4)3

Avg EPS beat(4)14.1%

Min EPS beat(4)-17.2%

Max EPS beat(4)44.44%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)16.67%

PT rev (3m)-39.79%

EPS NQ rev (1m)-5.93%

EPS NQ rev (3m)N/A

EPS NY rev (1m)-2.58%

EPS NY rev (3m)41.5%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	831.11
P/FCF	N/A
P/OCF	N/A
P/B	2.72
P/tB	2.72
EV/EBITDA	N/A

EPS(TTM)-1.53

EYN/A

EPS(NY)-1.49

Fwd EYN/A

FCF(TTM)-1.38

FCFYN/A

OCF(TTM)-1.34

OCFYN/A

SpS0

BVpS0.58

TBVpS0.58

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-65.17%
ROE	-247.79%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	46.24%
FCFM	N/A

ROA(3y)-97.75%

ROA(5y)-92.56%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	1.06
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	260.71%
Cap/Sales	1897.85%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.63
Quick Ratio	3.63
Altman-Z	-7.19

F-Score5

WACC9.08%

ROIC/WACCN/A

Cap/Depr(3y)132.87%

Cap/Depr(5y)81.29%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)17.85%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-7.02%

EPS Next Y2.89%

EPS Next 2Y-4.99%

EPS Next 3Y8.48%

EPS Next 5YN/A

Revenue 1Y (TTM)-22.5%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-57.14%

Revenue Next Year-100%

Revenue Next 2Y-41.42%

Revenue Next 3Y536.61%

Revenue Next 5YN/A

EBIT growth 1Y-83.99%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year6.1%

EBIT Next 3Y-7.57%

EBIT Next 5YN/A

FCF growth 1Y-55.82%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-53%

OCF growth 3YN/A

OCF growth 5YN/A

FRACTYL HEALTH INC (GUTS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens